Dopamine and disease.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy; D000818:Animals; D001249:Asthma / Q000188:drug therapy; D001714:Bipolar Disorder / Q000188:drug therapy; D010244:Bulbar Palsy, Progressive / Q000188:drug therapy; D003704:Dementia / Q000188:drug therapy; D003711:Demyelinating Diseases / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D004298:Dopamine / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy; D007668:Kidney / Q000187:drug effects; D008171:Lung Diseases / Q000188:drug therapy; D008297:Male; D020149:Manganese Poisoning; D009129:Muscle Tonus; D009135:Muscular Diseases / Q000188:drug therapy; D009886:Ophthalmoplegia / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D011605:Psychoses, Substance-Induced / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000209:etiology
D004298:Dopamine